Tracking the Recruitment of Diabetogenic CD8+ T-Cells to the Pancreas in Real Time

  1. Anna Moore1,
  2. Jan Grimm2,
  3. Bingye Han3 and
  4. Pere Santamaria3
  1. 1Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts
  2. 2Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
  3. 3Julia McFarlane Diabetes Research Center and Department of Microbiology and Infectious Diseases, University of Calgary, Alberta, Canada
  1. Address correspondence and reprint requests to Anna Moore, PhD, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Building 149, 13th Street, Room 2301, Charlestown, MA 02129. E-mail: amoore{at}helix.mgh.harvard.edu

Abstract

Development of autoimmune diabetes in both humans and mice is preceded by a prolonged period of inflammation of pancreatic islets by autoreactive T-cells. Noninvasive imaging techniques, including positron-emission tomography and optical or magnetic resonance imaging, have been used to track the recruitment of lymphocytes to sites of inflammation. These techniques, however, rely on labeling strategies that are non–antigen specific and do not allow specific tracking of the recruitment of autoreactive lymphocytes. Here we describe an antigen-specific magnetic label to selectively target a prevalent population of diabetogenic CD8+ T-cells that contribute to the progression of insulitis to overt diabetes in NOD mice. Superparamagnetic nanoparticles coated with multiple copies of a high-avidity peptide/major histocompatibility complex ligand of these T-cells (NRP-V7/Kd) are endocytosed by CD8+ T-cells in an antigen-specific manner. Using these T-cells as probes, we show that inflammation of pancreatic islets by autoreactive T-cells can be detected in real time by magnetic resonance imaging. This study demonstrates the feasibility of visualizing the presence of ongoing autoimmune responses noninvasively.

Footnotes

    • Accepted March 8, 2004.
    • Received December 1, 2003.
« Previous | Next Article »Table of Contents